The pregnancy-specific glycoprotein (PSG) genes encode a group of proteins which are found in large amounts in placenta and maternal serum. In situ hybridization analyses of metaphase chromosomes reveal that all the human pregnancy-specific glycoprotein (PSG) genes are located on the long arm of chromosome 19 (19q13.2-13. 3), overlapping the region containing the closely-related carcinoembryonic antigen (CEA) gene subgroup. Higher resolution analyses indicate that the PSG genes are closely linked within an 800kb Sac11 restriction endonuclease fragment. This has been confirmed through restriction endonuclease mapping and DNA sequence analyses of isolated genomic clones, which show that at least some of these genes are located in very close proximity. Further, these studies have helped to identify a new member of the PSG gene subfamily (PSG7). DNA/RNA hybridization analyses, using gene-specific oligonucleotide probes based on published sequences, showed that five from six PSG genes tested are coordinately transcribed in the placenta. Due to the close proximity of these genes and their coordinated expression pattern, common transcriptional regulatory elements may exist. 0 1990 Academic Press, Inc.
The pregnancy-specific 81 glycoproteins (PSG) consist of a heterogenous group of molecules (1) which are expressed in the placenta during pregnancy and in tumors of trophoblastic origin (2). At term pregnancy, the PSG molecules represent some of the major placental proteins (3). Their presence in choriocarcinomas has indicated their potential utility as tumor markers (2). Until recently, little was known about the structure and complexity of this protein family, and their function still remains unknown. At least three immunologically-crossreacting PSG species with differing molecular sizes have been isolated from human placenta (4). Through molecular analyses of genomic and cDNA clones, ten separate PSG genes have been identified so far, and their coding regions could be deduced (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Differential splicing of at least one gene has been reported, whereby four mRNA variants have been found, encoding proteins which differ only in their short C-terminal domain regions (4, 5, 9, 11, 14) . This increases the potential number of PSG proteins to thirteen, assuming that all the transcripts are translated. Sequence comparisons reveal that these genes are homologous to those encoding the carcinoembryonic antigen (CEA) and related molecules (15). The PSG/CEA gene family belongs to the immunoglobulin (Ig) superfamily (15, 16) . Basically, as derived from DNA sequence data, the proteins consist of one N-terminal Ig variable (IgV)-like, and a differing number of immunoglobulin constant (IgC)-like domains (17). Differences can be found in the C-terminal domain regions, whereby the CEA-related proteins appear to be membrane-bound, either after post-translational modification through processing and the addition of a glycosyl phosphatidylinositol tail (l&22), or as an integral membrane protein (23, 24) . Most of the PSG molecules apparently lack a transmembrane region and their deduced primary structures indicate that they are secreted (4, 5, 8, 9, 11 ).
The CEA-related genes are clustered on the long arm of chromosome 19 (25-27) . In this paper we have determined the fine chromosomal location of the PSG genes. DNA/RNA hybridization investigations using presumed gene-specific oligonucleotides have been applied to study the transcriptional activity of individual genes. These basic studies should help us to learn more about the regulation of PSG gene expression, and pave the way for functional analyses of this important group of pregnancy-specific glycoproteins.
MATERIALS AND METHODS

In situ hybridization:
Preparation of chromosomes and in situ hybridizations were carried out as described previously (27) using a 1026bp EcoRI/SstI restriction endonuclease fragment from XhsCGM3-1 (10) which contains the N-terminal domain exon, as a probe. After 3 weeks exposure at 4"C, the chromosomes were RBG-banded by the method of Perry and Wolff (29 Fiddes and Goodman (36) , as described elsewhere (27). Poly(A) RNA was purified once over an oligo(dT) column and size separated on methylmercury hydroxide denaturing agarose gels as described (27). Gene-specific oligonucleotides which were complementary to corresponding mRNAs were synthesized, based on known DNA sequence data, from the N-terminal domains of different PSG genes (Table I) . Hybridization was carried out in 20-30% deionized formamide, 1% SDS, 1M NaCl, 10% dextran sulphate, lOO~g/ml denatured salmon sperm DNA at lo-15°C below the theoretical melting temperatures (33). The final washes were performed in 2-6x SSPE at a temperature where only hybrids with none or maximally one mismatch are stable.
Primer extension experiments:
In order to determine the transcriptional start for two PSG genes, gene-specific oligonucleotides which are complementary to corresponding mRNA species were used to prime extension reactions.
For PSGS, the oligonucleotide used was oligo PSGS (Table  I ). For comparison, we used an oligonucleotide from the S-untranslated region of PSGl (oligo PSGl-5'= SGATAAGCCTAGGATCCAGAA-CKT 3'), based on sequence data from a corresponding genomic clone (XPSflG-1:
[lo], and unpublished data). For the annealing reaction, 5-long, S-end labelled oligonucleotide was mixed with 2.5pg poly(A) RNA isolated from a term placenta, in 10,Ul 5mM sodium phosphate buffer pH 7.0, 5mM EDTA. After 5 min denaturation at 9O"C, 0.4 1.11 2M NaCl was added and hybridization took place in separate reactions at 40, 45, 50, 55 or 60°C for l-2h. After this time the mixtures were either allowed to cool slowly to room temperature, or were directly taken for the extension reaction. to predict that all the members of the PSG gene subgroup but not from the CEA subgroup, should cross-hybridize with the XhsCGM3-1 probe (10) used, which corresponds to the gene PSG6 (13) under the conditions applied.
Therefore, it appears that all the genes belonging to the PSG gene-subgroup are clustered on the long arm of chromosome 19 ( Figure 1A ). Finer mapping of the grain distribution locates this gene cluster to 19q13.2-q13.3 ( Figure 1B ). Closer studies regarding their location were carried out by pulsed field gel electrophoresis analyses. In order to test the hybridization stringency conditions for PSG gene subgroup specificity, isolated cosmid clones, cosPSG4/5-1 and cosPSG4/5-2 (see below), as well as lambda clones XhsPSjIG-1 and XhsCGM3-1 (lo), which, according to the newly proposed nomenclature system (13), contain the genes encoding PSG4, PSGS, PSGl (formerly named PSBG) and PSG6 (formerly named hsCGM3) respectively, were co-hybridized as positive controls. Cosmid clone cosCEA1 (data to be published) and lambda clones X39.2 (37) and XhsCGM2-1 (lo), which contain the CEA, NCA and hsCGM2 genes, respectively, were co-hybridized as negative controls. Under the stringency conditions shown, all the PSG genes were found to hybridize, whereas the negative controls did not (results not shown was not carried out, but the high sequence similarity of all the PSG genes would suggest that they too should be positive under the stringency conditions applied. It can, therefore, be concluded that the strong signal seen in the genomic analysis ( Figure 2 ) probably represents all the PSG genes, which are localized within an 800kb Sac11 restriction endonuclease fragment. The weaker band at around 980kb represents the region of limited mobility for large DNA fragments. This could contain incompletely digested DNA fragments, although it cannot be ruled out that a small number of PSG genes are located on at least one other, larger DNA fragment. and DNA sequencing was carried out for these different clones in order to determine the exon/intron structures and the identity of the genes contained therein ( Figure 3B ). It could be confirmed that the two cosmid clones overlap through DNA sequencing. Together these clones contain the entire coding regions of two PSG genes, PSG4 and PSGS.
In parallel to the cosmid analyses, a lambda library was screened adopting the following strategy.
Since the PSG cDNA insert of pSP,-i (8) contained internal BamHI cleavage sites, it was supposed that digestion of genomic DNA clones with BamHI, followed by hybridization with pSP,-i might aid mapping. Of seven independent clones analysed, five contained two characteristic cDNA-hybridizing BamHI fragments of 0.7 and 2.3kb. Clone XPSG6/7-1 also contained an additional cDNA-hybridizing band of 1.7kb, and was thus chosen for further analysis as containing potentially the most structural information. This lambda clone indeed contains sequences from two neighbouring PSG genes ( Figure 3A ). The N-terminal domain exon of the S-lying gene is not present within this clone and it cannot be identified with respect to known PSG genes. However, the high sequence similarity to other PSG genes in the corresponding repeat domain exons reveals its identity as a member of this gene subgroup (92-97% at the nucleotide level), rather than the CEA subgroup (66-78%). Furthermore, sequence comparisons of these exons with the corresponding regions for other members of the PSG subgroup reveal that they differ from all known sequences. For this reason, we have designated this gene PSG7, which has already been included in the list compiled by Barnett and Zimmermann (13) . The second gene (PSG6) in this clone is identical in its N-terminal domain exon to the recently described hsCGM3 gene (lo), and corresponds to the cDNA clone XPSG6, described recently (11).
DNA sequencing of all three clones was restricted to the whole exons and parts of their surrounding introns. For PSG.5, the putative promoter region was sequenced as far as 380 nucleotides upstream from the initiator codon. The sequence data are not presented here, but are being forwarded to GenBank, Los Alamos, USA.
Identification of transcripts for individual
PSG genes: We have started to study the expression patterns of individual PSG genes, which may be expected to be coordinated, due to their tight linkage and strong sequence similarities. Gene-specific oligonucleotides were synthesized after comparing the DNA sequences from the N-terminal domains of known PSG genes or their transcripts (Table I) . Each of these oligonucleotides should, at a high stringency, only hybridize with transcripts of one PSG gene. This was first calculated for each oligonucleotide according to Lathe (33) and confirmed for oligo PSG2 and oligo PSG4 by hybridizing them with isolated PSG Vol. 167, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICALRESEARCH COMMUNICATIONS The corresponding cDNA/genomic clones from which they are derived are shown i n brackets.
genomic clones (data not shown). On hybridizing all these oligonucleotides with poly(A) RNA from placenta, transcripts for five of the genes (PSGl-5) could be identified ( Figure 4A , even numbered lanes). Although it cannot be conclusively ruled out that one or the other oligonucleotide could cross-hybridize with transcripts from more than one PSG gene, the different hybridization patterns using the various oligonucleotides indicate a high degree of specificity for the individual probes.
Only oligonucleotides PSG2 and PSGS show a similar hybridization signal. This is probably due to the fact that the corresponding transcripts are of similar sizes, as deduced from published cDNA data (6,9), rather than to cross-hybridization. For some of these oligonucleotides, more than one transcript could be visualized, e.g. for oligo PSGl, two mRNA species ( Figure 4A , lane 2) and with oligo PSG4, three could be differentiated ( Figure 4A , lane 8). Poly(A) RNA from a colon adenocarcinama, which could be shown to contain mRNAs for CEA ( Figure 4B , lane l), was also hybridized, whereby no transcripts for any of the PSG genes could be identified ( Figure 4A , odd numbered lanes). Furthermore, CEA transcripts could not be found in the placenta ( Figure 4B , lane 2).
Due to differences in the specific activities of the radioactively-labelled oligonucleotides, it is not Table I ): oligo PSGl (lanes 1 and 2). oligo PSG2 (lanes 3 and 4), oligo PSG3 (lanes 5 and 6). oligo PSG4 (lanes 7 and 8), oligo PSGS (lanes 9 and 10) and oligo PSG6 (lanes 11 and 12), which are specific for the genes indicated above. (B) col on tumor (l ane 1) and term placenta (l ane 2), hybridized with the RsaI/PstI fragment from the 3'-untranslated region of the pCEA3 &CIA cl one &scribed elsewhere (11) and washed at high stringency (O.lx SSPE, 0.1% SDS, 65°C).
Vol.
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No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS no transcript could be found in the placenta using the PSG6 gene-specific oligonucleotide, which as a control, did hybridize with the corresponding genomic clone XhsCGM3-l(l0) under the same hybridization conditions (data not shown). No gene-specific oligonucleotide was tested for PSG7.
Determination
of the transcriptional starts for two PSG genes: As a basis for studying the promoter regions of PSG genes in a search for common regulatory elements, we have determined the transcriptional start sites for the PSGl and PSGS genes. The oligonucleotide used for PSGl (oligo PSGl-5') exhibited an identical hybridization pattern with term placental poly(A) RNA (data not shown) to the gene-specific ohgo PSGl (cf. Figure 4A , lane Z), and was used because it is situated closer to the transcriptional start than oligo PSGl, thus allowing a more precise determination. Analysis of the primer extension experiments ( Figure 5A Vol.
167, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS starts for both the PSGl and PSGS genes, where the longest extension products lie 130-134 nucleotides upstream of the translational starts, in both cases. Hybridization at different temperatures only revealed this pattern at 45°C with oligo PSGl-5', and above or below, these bands were not seen (results not shown). Using oligo PSGS, similar patterns were found up to 5O"C, and above no signal was visible. The shorter, strong bands at approximately -100 may represent alternative start sites, because their presence or absence shows an identical annealing temperature dependence pattern to the -130 to -134 bands at the different annealing temperatures. In contrast, other, smaller extension products probably represent premature termination points, due to secondary, structural hindrance of the reverse transcriptase, because they reveal a different annealing temperature dependence. The Sl nuclease assay for PSGl ( Figure 5B ) confirms the multiple starts at the same positions found with the primer extension analyses. No recognizable TATA box could be identified for either gene.
DISCUSSION
The in situ hybridization analyses with metaphase chromosomes demonstrate, unequivocally, that all the PSG genes are located on the long arm of chromosome 19 at position q13.2-q13.3 ( Figure  lB ), close to the CEA subgroup genes, which are located at 19q13. 1-13.2 (25-27) . These results conflict with those reported elsewhere (5), which suggest that the PSG genes are located on chromosome 6 and the X chromosome. However, recently another group also located the PSG genes to chromosome 19 (38) and in parallel to our studies, a third group located these genes to 19q13.1-13.2 (39). The close proximity of the genes within the PSG subgroup as suggested through the pulsed-field gel electrophoresis studies (Figure 2 ) has been confirmed for some of these genes through restriction endonuclease mapping studies, whereby it could be shown in two cases that a distance of only ca. 6kb separates the transcriptional units of two pairs of PSG genes ( Figure 3A and B). The fact that this distance is conserved in the two cases analysed, along with the suggested localization of this complete gene subgroup within an 800kb Sac11 restriction endonuclease fragment, indicates that all the PSG genes are similarly clustered.
The existence of a gene cluster for the PSG genes, together with their strong sequence similarities suggests that the genes have evolved recently by unequal crossing over, which has led to gene multiplication. On comparing the PSG genes found here, it becomes obvious that certain restriction sites are conserved, especially in and around the exon regions. When comparing the restriction sites around the closely-related pairs of IgC-like exons (A, B), a stronger conservation between corresponding exons from different genes exists rather than between IgC-like exons within a gene, eg. the BamHI sites close to the A2/B2 exons are conserved in PSG7, PSG4 and PSG5 (see Figure 3 ). These sites are, however, only partially conserved in the Al/B1 exon regions of these genes, where intergene conservation of restriction endonuclease sites for SstI/BamHI can be found. Indeed this higher intergene IgC-like domain conservation is confirmed by DNA sequencing, where the derived amino acid sequence similarity is 90-95% for corresponding intergene repeat exons, but only 43-46% for internal repeat units (i.e. Al vs. A2, Bl vs. B2). Oikawa et al. (7) find similar results in their PSG gene, CGM35 @O-95% and 44-49%, respectively) . This suggests that during evolution, the IgC-like exon pairs within a primordial gene duplicated prior to the whole gene unit, whose own duplication gave rise to new PSG genes more recently. This supplements the evolutionary models which we have reported elsewhere (17, 40) . (5) and FL-NCA3 (h), respectively, both contain stop codons. In the case of PSG4, this is due to a point mutation, whereas in PSGS, a deletion of two nucleotides, when compared with the Bl exon of other PSG genes, leads to a frame shift, which is followed by a stop codon. The Al exon of PSG5, which is missing from the corresponding cDNA clone contains an open reading frame.
The nucleotide sequence determined downstream from the B2 exon of the PSG4 gene shows homology to the corresponding region region in the CGM35 gene (7). Furthermore, the conservation of the first EcoRI restriction endonuclease site, downstream of the B2 exon in the 3'-untranslated region of PSG4 ( Figure 3B ), with respect to the already sequenced CGM35 clone (7), indicates similarity to the latter further downstream. We also have provisional sequence data (not shown) downstream from this EcoRI site in PSG4 which confirm continued homology to the corresponding PSG4 cDNA (11) and the CGM35 clone (7). This whole region in CGM35 has been shown to contain a number of exons (7), which could be differentially spliced to give rise to four mRNA species, differing in their 3'untranslated regions, as shown for PSGl (11). The PSGS 3'-untranslated region, on the other hand, appears to differ with respect to the EcoRI site, and indeed the nucleotide sequence diverges from the PSG4 and CGM35 sequences (7), 152 nucleotides downstream from the 3'-end of the B2 exon (data not shown). This position coincides with the point of divergence between the CEA 3'untranslated region and the corresponding region in CGM35, as reported elsewhere (7). It was recently suggested that this divergence may have been caused by a deletion in the CGM35 gene and correspondingly in the PSG4 gene (11). This hypothesis is strengthened by the present data. We could identify the presence of a separate exon, downstream from B2 in PSGS through DNA sequencing, which contains coding information for the short C-terminal domain and the first 44 nucleotides of the 3'untranslated region, which confirms the model which we recently proposed (11). The rest of the 3'-untranslated region is encoded by at least one separate exon, which is not present within this cosmid clone, as confirmed by hybridization with an oligonucleotide from that region (data not shown). The 3'-untranslated region of PSG7 has not been analysed, but the conserved distance between PSG7 and PSG6 as compared to PSG4 and PSGS (Figure 3 ) would indicate similarity in the 3'-exon containing region to PSG4.
In order to see whether or not these closely linked PSG genes reveal similar expression patterns,
we have looked for individual PSG transcripts in the placenta and a colon tumor (Figure 4A ), Vol. 167, No. 2, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS whereby signals for five of six genes tested could be found in the placenta only. In a previous study, we were unable to detect transcripts for PSG genes in a number of tumor tissues (10). Together, these results indicate a high degree of tissue-specific expression. With the gene-specific oligonucleotides for PSGl and PSG4, multiple transcripts could be visualized ( Figure 4A , lanes 2 and 8). For PSGl, four mRNA splice variants have been described through cDNA cloning (4, 5, 9, 11, 14) .
A similar set of splice products can be predicted to exist for PSG4, PSG7 and CGM35 (7), which appear to have similar 3'-untranslated regions to PSGl (see above). For PSG2 ), PSG3 (=SPli [8] ) and PSGS, only one transcript could be found in each case ( Figure 4A , lanes 4,6 and 10). These three genes have previously been predicted, through cDNA analyses, to have a similar exon structure in their 3'-untranslated regions (ll), showing differences to the PSG4-related group. The smaller sizes of the PSG2 and PSGS mRNAs are probably due to a deletion, caused by alternative splicing, which has not been observed for PSG3. Although no transcript could be identified for PSGG, we have recently been able to confirm the transcriptional activity of this gene through the isolation of a corresponding cDNA clone (XPSGG) from a fetal liver cDNA library (11). No gene-specific oligonucleotides have so far been tested for PSG7.
The coordinated expression for five of the PSG genes in a tissue-specific manner suggests that common regulatory elements may control their transcriptional activities. The structural organization of these genes within a closely linked gene cluster would facilitate such controls. Alternatively, there is room for individual promoters between each PSG gene (Figure 3 ), which may, in analogy to the PSG coding sequences, also be highly conserved, following the suggested recent duplication of complete PSG gene units (cf.40) . This would in turn lead to highly similar regulation patterns.
Closer analyses of the putative promoter regions should clarity this.
